Han Zhang, Zhe-Li Liu, Peng Sun, Feng Gu. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AgedAged, 80 and overAngiogenesis Inhibitors/administration & dosageAngiogenesis Inhibitors/adverse effectsAntibodies, Monoclonal, Humanized/administration & dosageAntibodies, Monoclonal, Humanized/adverse effectsBevacizumabFemaleHallucinations/chemically inducedHallucinations/epidemiologyHumansIncidenceIntravitreal InjectionsMaleMiddle AgedSyndromeVascular Endothelial Growth Factor A/antagonists & inhibitorsWet Macular Degeneration/drug therapy
Substances： See more » Angiogenesis InhibitorsAntibodies, Monoclonal, HumanizedVEGFA protein, humanVascular Endothelial Growth Factor ABevacizumab
Year: 2012 PMID： 22490079 DOI： 10.1111/j.1755-3768.2012.02421.x
Source DB: PubMed Journal: Acta Ophthalmol ISSN： 1755-375X Impact factor: 3.761